The University of Southampton
University of Southampton Institutional Repository

Chronic consumption of cranberries (Vaccinium macrocarpon) for 12 weeks improves episodic memory and regional brain perfusion in healthy older adults: a randomised, placebo-controlled, parallel-groups feasibility study

Chronic consumption of cranberries (Vaccinium macrocarpon) for 12 weeks improves episodic memory and regional brain perfusion in healthy older adults: a randomised, placebo-controlled, parallel-groups feasibility study
Chronic consumption of cranberries (Vaccinium macrocarpon) for 12 weeks improves episodic memory and regional brain perfusion in healthy older adults: a randomised, placebo-controlled, parallel-groups feasibility study

Background: ageing is highly associated with cognitive decline and modifiable risk factors such as diet are believed to protect against this process. Specific dietary components and in particular, (poly)phenol-rich fruits such as berries have been increasingly recognised for their protection against age-related neurodegeneration. However, the impact of cranberries on cognitive function and neural functioning in older adults remains unclear.

Design: a 12-week parallel randomised placebo-controlled trial of freeze-dried cranberry powder was conducted in 60 older adults aged between 50 and 80 years. Cognitive assessment, including memory and executive function, neuroimaging and blood sample collection were conducted before and after the intervention to assess the impact of daily cranberry consumption on cognition, brain function and biomarkers of neuronal signalling.

Results: cranberry supplementation for 12 weeks was associated with improvements in visual episodic memory in aged participants when compared to placebo. Mechanisms of action may include increased regional perfusion in the right entorhinal cortex, the accumbens area and the caudate in the cranberry group. Significant decrease in low-density lipoprotein (LDL) cholesterol during the course of the intervention was also observed. No significant differences were, however, detected for BDNF levels between groups.

Conclusions: the results of this study indicate that daily cranberry supplementation (equivalent to 1 small cup of cranberries) over a 12-week period improves episodic memory performance and neural functioning, providing a basis for future investigations to determine efficacy in the context of neurological disease. This trial was registered at clinicaltrials.gov as NCT03679533 and at ISRCTN as ISRCTN76069316.

2296-861X
Flanagan, Emma
9f6e2c81-5431-4776-ac06-2b21e3572df6
Cameron, Donnie
aa118669-170a-4357-a074-e820842f81ee
Sobhan, Rashed
022beb54-f761-4ab1-9db9-cc19f190afa8
Wong, Chloe
e8e41141-4035-40fd-bcc1-353113dc60e9
Pontifex, Matthew G.
d7159875-59ff-47ed-8243-675a91a6fa65
Tosi, Nicole
9d9cb4cc-24b2-4cf4-95d0-5c33dd4533d1
Mena, Pedro
8c0a70c1-99c9-43c0-b440-6fb9c22bea91
Del Rio, Daniele
ea3db204-0c29-4041-844a-807c6c036bd7
Sami, Saber
e4536380-a4bf-46cd-bd45-6d44535fe8d9
Narbad, Arjan
d3df5ddb-6b81-485a-aade-5faf61011998
Müller, Michael
731566e0-9b1f-46b7-a645-cc7b1ae78161
Hornberger, Michael
a48c1c63-422a-4c11-9a51-c7be0aa3026d
Vauzour, David
2d0c859c-1f35-408d-ab41-730d76efd487
Flanagan, Emma
9f6e2c81-5431-4776-ac06-2b21e3572df6
Cameron, Donnie
aa118669-170a-4357-a074-e820842f81ee
Sobhan, Rashed
022beb54-f761-4ab1-9db9-cc19f190afa8
Wong, Chloe
e8e41141-4035-40fd-bcc1-353113dc60e9
Pontifex, Matthew G.
d7159875-59ff-47ed-8243-675a91a6fa65
Tosi, Nicole
9d9cb4cc-24b2-4cf4-95d0-5c33dd4533d1
Mena, Pedro
8c0a70c1-99c9-43c0-b440-6fb9c22bea91
Del Rio, Daniele
ea3db204-0c29-4041-844a-807c6c036bd7
Sami, Saber
e4536380-a4bf-46cd-bd45-6d44535fe8d9
Narbad, Arjan
d3df5ddb-6b81-485a-aade-5faf61011998
Müller, Michael
731566e0-9b1f-46b7-a645-cc7b1ae78161
Hornberger, Michael
a48c1c63-422a-4c11-9a51-c7be0aa3026d
Vauzour, David
2d0c859c-1f35-408d-ab41-730d76efd487

Flanagan, Emma, Cameron, Donnie, Sobhan, Rashed, Wong, Chloe, Pontifex, Matthew G., Tosi, Nicole, Mena, Pedro, Del Rio, Daniele, Sami, Saber, Narbad, Arjan, Müller, Michael, Hornberger, Michael and Vauzour, David (2022) Chronic consumption of cranberries (Vaccinium macrocarpon) for 12 weeks improves episodic memory and regional brain perfusion in healthy older adults: a randomised, placebo-controlled, parallel-groups feasibility study. Frontiers in Nutrition, 9, [849902]. (doi:10.3389/fnut.2022.849902).

Record type: Article

Abstract

Background: ageing is highly associated with cognitive decline and modifiable risk factors such as diet are believed to protect against this process. Specific dietary components and in particular, (poly)phenol-rich fruits such as berries have been increasingly recognised for their protection against age-related neurodegeneration. However, the impact of cranberries on cognitive function and neural functioning in older adults remains unclear.

Design: a 12-week parallel randomised placebo-controlled trial of freeze-dried cranberry powder was conducted in 60 older adults aged between 50 and 80 years. Cognitive assessment, including memory and executive function, neuroimaging and blood sample collection were conducted before and after the intervention to assess the impact of daily cranberry consumption on cognition, brain function and biomarkers of neuronal signalling.

Results: cranberry supplementation for 12 weeks was associated with improvements in visual episodic memory in aged participants when compared to placebo. Mechanisms of action may include increased regional perfusion in the right entorhinal cortex, the accumbens area and the caudate in the cranberry group. Significant decrease in low-density lipoprotein (LDL) cholesterol during the course of the intervention was also observed. No significant differences were, however, detected for BDNF levels between groups.

Conclusions: the results of this study indicate that daily cranberry supplementation (equivalent to 1 small cup of cranberries) over a 12-week period improves episodic memory performance and neural functioning, providing a basis for future investigations to determine efficacy in the context of neurological disease. This trial was registered at clinicaltrials.gov as NCT03679533 and at ISRCTN as ISRCTN76069316.

Text
fnut-09-849902 - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 19 April 2022
Published date: 19 May 2022

Identifiers

Local EPrints ID: 506485
URI: http://eprints.soton.ac.uk/id/eprint/506485
ISSN: 2296-861X
PURE UUID: 2d4b0d4f-c3e4-4e2e-8d12-da56fd608523
ORCID for Michael Hornberger: ORCID iD orcid.org/0000-0002-2214-3788

Catalogue record

Date deposited: 10 Nov 2025 17:36
Last modified: 11 Nov 2025 03:10

Export record

Altmetrics

Contributors

Author: Emma Flanagan
Author: Donnie Cameron
Author: Rashed Sobhan
Author: Chloe Wong
Author: Matthew G. Pontifex
Author: Nicole Tosi
Author: Pedro Mena
Author: Daniele Del Rio
Author: Saber Sami
Author: Arjan Narbad
Author: Michael Müller
Author: Michael Hornberger ORCID iD
Author: David Vauzour

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×